Pro-life Group Threatens Legal Action Against FDA Over Mifepristone Environmental Concerns

<p>Students for Life of America (SFLA), a pro-life organization, has issued a notice of intent to sue the Food and Drug Administration (FDA), alleging that the agency did not conduct necessary environmental testing for the abortion drug mifepristone, which could pose risks to waterways and wildlife.</p><p>The notice was filed on Thursday, prior to Dr. Heidi Overton's confirmation hearing to lead the FDA. SFLA claims that the FDA failed to consult two wildlife protection agencies regarding the drug's potential harmful effects on federally protected species, which they argue is a violation of the Endangered Species Act.</p><p>SFLA President Kristan Hawkins stated, "We expect these environmental concerns to be taken seriously. I know Dr. Overton is aware of these concerns. Or we expect to see the Trump FDA in court. That's where this will end." The FDA has 60 days to respond to the notice before a lawsuit is initiated. SFLA has previously submitted 11 citizen petitions urging the agency to take action.</p><p>In a response to one of these petitions on January 15, 2025, the FDA rejected SFLA's legal argument, asserting that it was not obligated to consult with the U.S. Fish and Wildlife Service or the National Marine Fisheries Service prior to mifepristone's approval.</p><p>The notice references six studies, four of which did not assess the presence of mifepristone in environmental water samples, to support claims that the drug may pose environmental risks that warrant further federal review. One cited study published in Issues in Law & Medicine reported anti-progesterone activity in water samples from three U.S. cities.</p><p>SFLA argues that since mifepristone blocks progesterone receptors, which are essential for sustaining pregnancy, the findings suggest that the drug has entered the U.S. water supply. Hawkins questioned, "Where do all the babies go in chemical abortions?" noting the high number of abortions induced with chemical abortion pills.</p><p>However, the study did not directly detect mifepristone in the water; it looked for indicators of substances that block progesterone, with researchers stating that another compound could have caused similar results. Confirming the presence of mifepristone would typically require advanced analytical chemistry techniques.</p><p>Hawkins emphasized that the legal notice is based on the FDA's failure to adhere to legal requirements in 2000, stating, "This should be something that unites all Americans, regardless of how you feel about the violence of abortion. I certainly am pro-life, I want to see abortion ended. But we all want clean drinking water." She noted that this message has resonated even with students who may not agree with SFLA's stance on abortion.</p><p>With new leadership at the FDA anticipated, Hawkins expressed her organization's intent to remind the agency of its responsibilities. She stated, "Today, Dr. Heidi Overton will be at the U.S. Senate, and we want to be very clear that when she gets to her desk, the first thing she sees is our notice of intent to sue." Hawkins concluded by asserting the need to hold the abortion industry and the government accountable for upholding laws designed to protect both people and wildlife.</p>